AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity.

MLA

Casana, Estefania, et al. “AAV-Mediated BMP7 Gene Therapy Counteracts Insulin Resistance and Obesity.” Molecular Therapy. Methods & Clinical Development, vol. 25, Mar. 2022, pp. 190–204. EBSCOhost, https://doi.org/10.1016/j.omtm.2022.03.007.

APA

Casana, E., Jimenez, V., Jambrina, C., Sacristan, V., Muñoz, S., Rodo, J., Grass, I., Garcia, M., Mallol, C., León, X., Casellas, A., Sánchez, V., Franckhauser, S., Ferré, T., Marcó, S., & Bosch, F. (2022). AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity. Molecular Therapy. Methods & Clinical Development, 25, 190–204. https://doi.org/10.1016/j.omtm.2022.03.007

Chicago

Casana, Estefania, Veronica Jimenez, Claudia Jambrina, Victor Sacristan, Sergio Muñoz, Jordi Rodo, Ignasi Grass, et al. 2022. “AAV-Mediated BMP7 Gene Therapy Counteracts Insulin Resistance and Obesity.” Molecular Therapy. Methods & Clinical Development 25 (March): 190–204. doi:10.1016/j.omtm.2022.03.007.